Christophe Leclercq
Christophe Leclercq is an expert in Cardiology at Centre Hospitalier Universitaire de Rennes (France). As of October 2026, ScienceLeadR ranks Christophe Leclercq in the top 1% of experts worldwide for Electric Stimulation Therapy, Heart Failure and Arrhythmias, Cardiac. Christophe Leclercq has authored 574 publications, the most recent in 2026, and is an investigator in 33 clinical trials, 4 of them ongoing. SLR score: 1,884 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Public Health - Biostatistics - Physical Medicine
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2002 - 2026
Number : 574
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Long-Term Outcome Following Idiopathic Ventricular Fibrillation and Potential Emerging Etiologies. PMID 42900029 — mortality, arrhythmias, cardiac, cardiovascular diseases, cohort studies, ventricular fibrillation, diagnosis, death, sudden, cardiac | JACC Clin Electrophysiol | 2026 | 0 |
| Mortality reduction with implanted defibrillator for primary prevention of sudden death after Myocardial Infarction: temporal trends in the PROFID study. PMID 42663237 — death, sudden, mortality, myocardial infarction, heart failure, primary prevention, therapeutics, defibrillators | Eur Heart J Top journal | 2026 | 0 |
| Impact of a Mobile Reference Application on the Efficiency and Accuracy of CIED Data Retrieval: A Comparative Pilot Study. PMID 42578938 — pilot projects, pilots | Europace | 2026 | 0 |
| Redefining response to Cardiac Resynchronisation Therapy: A Post-hoc Analysis of the MORE-CRT MPP trial. PMID 42573152 — disease-free survival, cardiac resynchronization therapy, therapeutics, non-responder | Europace | 2026 | 0 |
| Subcutaneous Implantable Cardioverter-Defibrillator Therapy in Women. PMID 42554569 — mortality, epidemiology, cardiovascular diseases, cohort studies, heart arrest, sex, death, sudden, cardiac, therapeutics, defibrillators, implantable, defibrillators | JACC Clin Electrophysiol | 2026 | 0 |
Clinical Studies 33
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 4
Ongoing Clinical Trials
4 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| ASCEND CSP IDE Study NCT06830746 — research design, heart failure, heart, arrhythmias, cardiac | N/A | Active not recruiting | 2025 |
| French Cohort Evaluating the effectiveneSs of Atrioventricular Synchrony by the micRa AV NCT05953558 — quality of life | N/A | Recruiting | 2023 |
| Cardioverter DefIbriIlator PlacEMent for priMary Prevention of Sudden cArdiac Death in Patients Older Than 70 Years NCT05373940 — mortality, heart failure, heart, secondary prevention, cardiac resynchronization therapy, primary prevention, death, sudden, cardiac, therapeutics, defibrillators, implantable, defibrillators | N/A | Recruiting | 2022 |
| Tendyne European Experience Registry NCT04898335 — registries, mitral valve, mitral valve insufficiency, transcatheter mitral valve replacement | N/A | Recruiting | 2021 |
LeadR Networks
Main global connection map